HSPA8 and cholangiocarcinoma: Our study found that HSPA8 knockdown inhibited the proliferation and migration of HCCC-9810 and HUCCT1 cells, and decreased the percentage of S phase cells, besides, reversed the effects of RPL35A overexpression on CCA cells.